BioNexus Gene Lab Corp Common stock
Specialty Chemicals
Basic Materials
BGLC
1.80 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
5.47
52 week high
11.14
high
5.47
52 week low
0.00
low
5.16
growth
100.00 %
previous Close
5.49
P/E ratio
market cap
10.28 M
div yield
0
usd
Jun 2025
qoq
revenue
2.26 M
5.76 %
net incoming
-616.17 K
1.15 %
eps
0.00 %
1.99 %
eps surprise
0.00 %
net profit margin
-27.26 %
1.00 %
operating incoming
-699.99 K
-13.19 %
net change in cash
-552.25 K
30.75 %
cash on hand
814 K
-25.39 %
cost of revenue
1.89 M
5.50 %
top top